Login / Signup

Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial.

Nazanin BondadReza BoostaniAlireza BarriSepideh ElyasiAbolghasem Allahyari
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
The results of this study showed that N-acetylcysteine could reduce the incidence of the neuropathy induced by oxaliplatin and delay its occurrence in patients with gastric or colorectal cancers.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • risk assessment
  • high glucose
  • open label
  • phase ii study
  • diabetic rats
  • randomized controlled trial
  • drug induced
  • young adults